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PRECLINICAL STUDY
ypoxia-Inducible Factor 1-Alpha Reduces
nfarction and Attenuates Progression of Cardiac
ysfunction After Myocardial Infarction in the Mouse
asakuni Kido, MD,* Lingling Du, MD,* Christopher C. Sullivan, MS,* Xiaodong Li, MD, PHD,*
eena Deutsch, PHD,† Stuart W. Jamieson, MB, FRCS,* Patricia A. Thistlethwaite, MD, PHD*
an Diego, California
OBJECTIVES The aim of this research was to test whether constitutive expression of hypoxia-inducible
factor 1-alpha (HIF-1) influences infarction size and cardiac performance after myocardial
infarction.
BACKGROUND A major question in clinical medicine is whether infarction size and border zone remodeling
of the heart can be influenced by the overexpression of specific genes in the peri-infarction
region.
METHODS We investigated the role of constitutive HIF-1 expression in acute myocardial infarction
using a transgenic model. Transgenic mice containing the HIF-1 gene under the control of
the -myosin heavy chain promoter were constructed. Myocardial infarction was produced by
coronary ligation in HIF-1 transgenic mice and control animals. Extent of infarction was
then quantitated by two-dimensional and M-mode echocardiography as well as by molecular
and pathologic analysis of heart samples in infarct, peri-infarct, and remote heart regions at
serial time points.
RESULTS Constitutive overexpression of HIF-1 in the murine heart resulted in attenuated infarct size
and improved cardiac function 4 weeks after myocardial infarction. Significantly, we found an
increase in both capillary density as well as vascular endothelial growth factor and inducible
nitric oxide synthase expression in peri-infarct and infarct regions in the hearts of constitutive
HIF-1–expressing animals compared to control animals.
CONCLUSIONS These observations suggest the involvement of HIF-1 in myocardial remodeling and
peri-infarct vascularization. Our results show that supranormal amounts of this peptide
protect against extension of infarction and improve border zone survival in myocardial
infarction. (J Am Coll Cardiol 2005;46:2116–24) © 2005 by the American College of
ublished by Elsevier Inc. doi:10.1016/j.jacc.2005.08.045Cardiology Foundation
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acute myocardial infarction (MI) causes approximately 2
illion deaths per year (1). In acute myocardial infarction,
rognosis and mortality rates are closely related to infarct
ize and the progression of postinfarction cardiac failure.
ypoxia-inducible factor 1 (HIF-1) is a major regulator of
he hypoxic response after myocardial infarction (2). This
ranscription factor consists of two basic-helix-loop-helix-
AS transcription factors, HIF-1 and HIF-1 (3).
IF-1 is sensitive to hypoxia and is rapidly degraded by
he ubiquitin proteasomal pathway under normoxic condi-
ions. Decreased tissue oxygen causes altered availability of
IF-1 to the von Hippel-Lindau protein and ubiquitina-
ion, blocking its degradation (4,5). This results in nuclear
ccumulation of HIF-1 protein and enhancement of its
ranscriptional activity through binding to enhancer elements
n target genes that include vascular endothelial growth
From the *Division of Cardiothoracic Surgery and †Division of Biostatistics,
niversity of California, San Diego, San Diego, California. Supported by NIH R01
L70852 to Dr. Thistlethwaite and NIH M01 RR00827 to Dr. Deutsch. The first
wo authors contributed equally to this work. Douglas Losordo, MD, FACC, served
s guest editor for this article.5
Manuscript received February 9, 2005; revised manuscript received July 12, 2005,
ccepted August 1, 2005.actor (VEGF) (6), inducible nitric oxide synthase (iNOS)
7), erythropoietin (8), and phosphoglycerate kinase (9).
We have previously shown that the HIF-1 gene is
p-regulated in regions of myocardial infarction and isch-
mia (2). However, the role of HIF-1 in ischemic myo-
ardium and myocardial remodeling after infarction is
nknown. To this end, we asked whether constitutive
igh-level expression of HIF-1 in the myocardium would
nfluence myocardial infarction size and improve cardiac
erformance in the mouse after myocardial infarction.
ETHODS
ransgenic mice. The pBSKII-MHC-SV40-HIF-1
ector was constructed by subcloning the HIF-1 cDNA
nto the EcoRV cloning site of the pBSKII-MHC-
V40 plasmid (gift from K. Chien, University of Cali-
ornia, San Diego) (10). After digestion with BssHII, the
ragment carrying the MHC promoter and HIF-1
DNA was used for microinjection into C57BL/6 zy-
otes. Four independent transgenic lines were established
nd studied. Transgenic mice were identified by PCR
nalysis of tail genomic DNA using the forward primer
=-GACGGTATCGATAAGCTTGAT-3= (derived from
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December 6, 2005:2116–24 HIF-1 Reduces Myocardial Infarctionequence in our plasmid construct) and the reverse primer
=-CTCGGCTAGTTAGGGTACACTTC-3= (derived
rom HIF-1 sequence). To perform experiments in ho-
ozygous HIF-1 transgenic mice, we backcrossed for six
enerations. HIF-1 () mice were homozygous negative
nimals derived from the F2 generation. Animal experi-
ents were performed in accordance with the protocols
pproved by the institutional animal care and use committee
nd complied with recommendations published in Guide for
he Care and Use of Laboratory Animals (National Academic
ress, Washington, DC, 1996).
urgical procedures. Twelve-week-old male adult mice [50
IF-1() and 50 HIF-1() transgenic mice] were
nesthetized with 1.0% isoflurane inhalation via nose cone.
midline anterior cervical skin incision was made and the
rachea exposed by sharp dissection. The trachea was
ntubated with a 22-gauge angiocatheter and the position of
he tube was confirmed by direct visualization. Pressure-
ontrolled ventilation (animal ventilator from Kent Scien-
ific, Torrington, Connecticut) was initiated at 15 cm H2O.
1.5-cm vertical left parasternal skin incision was made,
he chest cavity was entered through the fourth interspace,
nd the pericardium vertically opened. The left anterior
escending coronary artery (LAD) was ligated with a 7-0
olypropylene suture. Ventricle blanching indicated success-
ul occlusion of the vessel. Sham-operated animals [45
IF-1() and 45 HIF-1() transgenic mice] served as
urgical controls and were subjected to the same procedures
s the experimental animals with the exception that the
AD was not ligated. Mortality rates during and after
urgery were 2% in all groups.
ransthoracic echocardiography. Two-and-one-half-
ercent Avertin (2,2,2-tribromoethanol) was administered
ntraperitoneally at 0.01 ml/g of body weight for mild seda-
ion. Echocardiographic analysis was performed using a com-
ercially available echocardiograph (SONOS 5500, Philips
lectronics, Amsterdam, the Netherlands) equipped with a
5-MHz linear array ultrasound transducer. The LV was
ssessed in both parasternal long-axis and short-axis views
t a frame rate of 120 Hz. End-systole or end-diastole was
efined as the phase in which the smallest or largest area of
V, respectively, was obtained. Left ventricular end-systolic
iameter (LVESD) and left ventricular end-diastolic diam-
ter (LVEDD) were measured from the LV M-mode
racing with a sweep speed of 50 mm/s at the papillary
Abbreviations and Acronyms
EF  ejection fraction
HIF-1  hypoxia-inducible factor 1-alpha
iNOS  inducible nitric oxide synthase
LAD  left anterior descending coronary artery
LV  left ventricle/ventricular
PCR  polymerase chain reaction
VEGF  vascular endothelial growth factoruscle level. Percentage fractional shortening (%FS) was palculated using standard formulas: %FS  [(LVEDD 
VESD)/LVEDD]  100. Akinetic area and other cardiac
arameters were also measured in the two-dimensional view
oth in long and short axis (11). Ejection fraction (EF) was
easured by single-plane area length and calculated accord-
ng to the formula: EF (%)  [(0.85 LVAD2/LVLD) 
0.85 LVAS2/LVLS)]/(0.85 LVAD2/LVLD)  100,
here LVAD left ventricular area in end-diastole; LVAS
left ventricular area in end-systole; LVLD  left ven-
ricular long-axis length in end diastole; and LVLS  left
entricular long-axis length in end-systole.
orphometric determination of infarct size at 24 h or 4
eeks. Two different histologic techniques were performed
o detect the extent of infarcted myocardium depending on
he time after coronary artery ligation (12). First, in order to
alidate the accuracy of echocardiography in the noninvasive
valuation of infarct size in mouse hearts 24 h after ligation,
.4 ml of 1% Evans blue dye in phosphate-buffered saline
PBS) was retrogradely injected into the coronary circula-
ion to delineate the nonischemic area in 20 animals [10
IF-1() and 10 HIF-1()]. Hearts were excised and
insed in iced PBS. Six biventricular sections of 0.8 mm
hickness were made perpendicular to the long axis of the
eart (between the point of ligation and the apex of the
eart) and incubated in 1% triphenyl tetrazolium chloride
TTC) (Sigma, St. Louis, Missouri) in PBS (pH 7.4) for 15
inutes at 37°C, fixed in 10% phosphate-buffered formalin,
nd digitally photographed at 10 magnification. For each
lice, the area of infarction and the total area of the LV were
lanimetered on a 10:1 grid and reconstructed using Scion
maging software (Scion Corp., Frederick, Maryland). Area
t risk (AAR) and infarct area were delineated and calcu-
ated for both sides of the section. AAR was calculated as
he left ventricular area excluding Evans blue after coronary
igation. Infarct area was determined as the risk area that
ecame necrotic as distinguished by TTC staining (TTC
tains noninfarcted areas red). Infarct area was also validated
y blinded histologic review of slides by a cardiac patholo-
ist. Cumulative areas for all sections from each heart were
sed for comparisons.
Second, for hearts studied 4 weeks after coronary ligation
20 animals: 10 HIF-1() and 10 HIF-1()], organs
ere excised and placed in 10% phosphate-buffered forma-
in. The gross infarct size was measured in the intact heart
y comparison of the length and width of the infarct and
V areas. The fixed tissue was embedded in paraffin and
erially cut from the apex to the level just below the coronary
rtery ligation site. Transverse 5-m-thick sections were cut
t intervals of 500 m, such that 14–18 sections were
btained from each heart. Alternating sections were stained
ith either hematoxylin/eosin or Masson trichrome. The
nfarcted area was measured by planimetry using Scion
maging software and expressed as a percentage of total
urface area of the left ventricle. Peri-infarct (border-zone)
egion was defined as the 2-mm area encircling the area of
athologic infarction.
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HIF-1 Reduces Myocardial Infarction December 6, 2005:2116–24Parameters were calculated using the equations:
% infarct size (infarct area⁄total LV area) 100
% infarct thickness (anterior wall [infarct thickness]⁄
septal wall thickness) 100
viable LV area total LV myocardial area
 infarct myocardial area
endocardial infarct length (endocardial infarct length⁄
endocardial LV circumferences) 100
epicardial infarct length (epicardial infarct length⁄
epicardial LV circumferences) 100
mmunohistochemistry and vascular density. Hearts
ere fixed in 10% phosphate-buffered formalin. Paraffin-
mbedded hearts were cut into 5-m slices. Adjacent
ections (taken at the midpoint between LAD ligation site
nd apex) were stained with rabbit polyclonal antibodies
gainst CD31 or alpha-myosin heavy chain (both from
anta Cruz Biotechnology, Santa Cruz, California), a
ouse monoclonal antibody against HIF-1 (Novus Bio-
ogical, Littleton, Colorado), a mouse monoclonal antibody
gainst VEGFA, or a rabbit polyclonal antibody against
NOS (both from Santa Cruz Biotechnology): 50 sections/
eart with 10 sections stained with each antibody, 10
earts/group [groups: HIF-1()/LAD ligation, HIF-
()/LAD ligation, HIF-1()/sham, and HIF-1()/
ham]. Staining for CD31 and iNOS was performed using
he Vectastain ABC kit, and the Vector MOM immuno-
etection kit was used for HIF-1 and VEGFA staining,
oth according to the manufacturer’s instructions (Vector
aboratory, Burlingame, California). The sections were
eveloped in H2O2 and diaminobenzidine tetrahydrochlo-
ide and counterstained by hematoxylin. Capillary density
as expressed as CD31 endothelial cells per high-power
eld (200). Five high-powered fields were counted per
ection, with 10 sections/heart, and 10 hearts/group. All
tudies were performed by two independent blinded
nvestigators.
orthern and Western blotting. Northern and Western
lotting, including tissue extraction, electrophoresis, and
robe labeling, were performed as previously described (13).
or Northern blotting, the 32P-labeled probe generated for
ransgenic HIF-1 spanned base pairs 4895 to 5405 within
he -MHC promoter of the vector construct; while the
robe specific for endogenous HIF-1 spanned base pairs
775 to 3200 of murine HIF-1 mRNA within the 3=
ntranslated region. For Northern and Western analysis,
nfarct tissue was defined as the portion of myocardium that
as grossly pale at 24 h or contained visible scar at 4 weeks;
eri-infarct tissue was defined as the area of myocardium
ithin 2 mm of the visible edge of infarction; and remoterea was taken from the interventricular septum. Infarct, (eri-infarct, and regions remote to the infarct were exam-
ned independently (5 hearts/group examined at 24 h and 4
eeks after coronary ligation by Northern blot; 5 hearts/
roup at 24 h and 4 weeks after coronary ligation examined
y Western blot). The following antibodies were used: mouse
nti-HIF-1 (Novus Biological), mouse anti-VEGFA, rab-
it anti-iNOS, and mouse anti-actin (Santa Cruz Biotech-
ology). Induction of VEGF and iNOS expression was
uantified using the IS-1000 digital imaging system (Alpha
nnotech Corp., San Leandro, California) with actin band
ensities serving to normalize protein amounts.
tatistical analysis. Mean  standard error of the mean
SEM) was reported for each echocardiographic parameter
t two time points, 24 h and 4 weeks, within each of the two
IF-1 groups. We compared the HIF-1() and HIF-
() groups with respect to mean magnitude of change
rom 24 h to 4 weeks after LAD ligation. Student t tests
ere used for comparisons between HIF-1 groups, except
or infarct size, for which a Wilcoxon rank sum test was
sed because normal assumptions did not apply according to
Shapiro-Wilks test. Unadjusted p values are reported for
ach echo parameter based on the difference between within-
nimal-group mean changes over time (within-mouse dif-
erence between measurement at 4 weeks minus measure-
ent at 24 h). The correlation between echocardiographic
nd histologic infarct size was tested by linear regression
nalysis.
ESULTS
o assess the effect of constitutive HIF-1 expression on
yocardial infarction and tissue vascularization, we gener-
ted transgenic mice lines with full-length murine HIF-1
DNA under the control of the -myosin heavy chain
MHC) promoter (MHC-HIF-1) (10). Northern blot
nalysis of four independent mouse lines generated with the
MHC-HIF-1 transgene demonstrated the presence of
ransgenic HIF-1 message only in the myocardium and
ot in other organs, with equal levels of expression in adult
tria and ventricles. Morphometric analysis showed normal
oronary anatomy and no difference in the number of
D31-stained vascular structures in MHC-HIF-1
ransgenic mice hearts compared with that in age-matched
ontrols under normoxic conditions (data not shown).
We investigated the role of constitutive HIF-1 expres-
ion in the setting of acute myocardial infarction. Trans-
enic and age-matched control mice underwent LAD
igation, followed 24 h and 4 weeks later by M-mode and
wo-dimensional cardiac echocardiography as well as patho-
ogic and molecular analysis of their hearts. Coronary artery
igation in the mouse produces a broad spectrum of ventric-
lar dysfunction, ranging from mild impairment to overt
eart failure. We excluded animals that had akinetic areas
ore than 50% of the total left ventricular area as detected
y echocardiography and clinical signs of heart failure
dyspnea and inability to feed) at 24 h after coronary ligation
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December 6, 2005:2116–24 HIF-1 Reduces Myocardial Infarctionrom further study. Two additional groups of HIF-1
ositive () and negative () animals underwent sham
peration excluding ligation of the LAD artery, followed by
igure 1. Echocardiographic measurement of akinetic area correlates with
athologic measurement of infarct size at 24 h (top panel) and 4 weeks
bottom panel) after coronary ligation. Linear regression analysis of the
orrelation between the percent infarction area/total ventricular area (as
easured by TTC or Masson trichrome staining/histology at 24 h and 4
eeks after coronary ligation, respectively) and the percent akinetic
rea/total ventricular area as measured by two-dimensional echocardiogra-
hy. For both timepoints n  20 animals; 10 HIF-1() (circles), 10
IF-1() (triangles).
able 1. Infarction Changes in LV After MI in HIF-1() and
Infarction
Size (%) AAR
4 h
HIF-1()/LAD ligation (n  10) 33.4  6.7 36.9 
HIF-1()/LAD ligation (n  10) 32.0  8.5 36.1 
HIF-1()/sham (n  5) — —
HIF-1()/sham (n  5) — —
Ant/Sept
Thickne
weeks
HIF-1()/LAD ligation (n  20) 31.9  4.2† 58.4 
HIF-1()/LAD ligation (n  20) 40.1  5.3 33.3 
HIF-1()/sham (n  10) — 123 
HIF-1()/sham (n  10) — 119 
alues indicate mean  SEM. Parameters were measured on the midline horizontal
roup at 4 weeks. †p  0.05 vs. HIF-1()/LAD ligation group at 4 weeks.
AAR (%)  (area at risk/total LV area)  100; ant/septal wall thickness (%)  (
%)  (endocardial length of infarction/endocardial LV circumference)  100; epica100; Infarction size (%)  (infarct area/total LV area)  100; viable LV area  total LV
escending coronary artery; LV  left ventricle; MI  myocardial infarction.chocardiographic, pathologic, and molecular evaluation of
heir hearts at similar time points.
orrelation between pathologic and echocardiographic
easurement of infarct size. Cohorts of animals were
acrificed at 24 h and 4 weeks after coronary ligation to
efine extent and reproducibility of infarction as well as
orrelation of acute infarction with echocardiographic pa-
ameters (Fig. 1). Twenty-four hours after coronary liga-
ion, HIF-1() and HIF-1() animals demonstrated a
imilar range of infarction areas (measured as the left
entricular area distinguished by absence of TTC staining)
nd areas at risk (measured as the left ventricular area
xcluding retrograde injection of Evans blue dye) (Table 1).
chocardiographic measurement of akinetic area correlated
irectly with the area of infarction at 24 h and 4 weeks after
AD ligation (Fig. 1). No infarct was detected in sham-
perated animals.
ene expression in infarct, peri-infarct, and septal regions
f the heart. We evaluated the expression of HIF-1 in
he infarcted heart. Northern blotting using probes specific
o either transgenic HIF-1 or endogenous HIF-1 dem-
nstrated two major findings (Fig. 2). First, steady-state
evels of transgenic HIF-1 mRNA were high throughout
trial and ventricular myocardium in HIF-1() mice
nder hypoxic and normoxic conditions and not detected in
IF-1() mice. The mRNA levels of transgenic HIF-1
ere not affected by hypoxic conditions (Fig. 2). Second, in
arly infarction (24 h after coronary ligation), levels of
ndogenous HIF-1 mRNA increase three-fold over levels
een under normoxic conditions in both HIF-1() and
IF-1() animals. By 4 weeks after infarction, steady-
tate levels of endogenous HIF-1 mRNA are low in peri-
nfarct tissue in both HIF-1() and HIF-1() mice.
By Western blotting, in control HIF-1() infarct
nimals, HIF-1 protein was detected 24 h after coronary
trol Mice
Viable LV
Area (mm2)
Endocardial
Infarction
Length (%)
Epicardial
Infarction
Length (%)
20.2  4.6 40.1  8.7 32.3  7.2
20.9  4.8 39.8  10.4 32.9  8.8
37.2  8.4 — —
36.3  9.3 — —
all
)
28.3  3.3* 39.8  10.5† 31.4  8.0
18.1  4.6 50.1  9.2 42.7  7.3
36.4  8.7 — —
37.8  9.4 — —
ns between ligation site and apex of heart. *p  0.01 vs. HIF-1()/LAD ligation
r wall (infarct) thickness/septal wall thickness)  100; endocardial infarction length
nfarction length (%)  (epicardial length of infarction/epicardial LV circumference)Con
(%)
9.8
8.2
al W
ss (%
9.6*
4.7
28.4
29.0
sectio
anterio
rdial imyocardial area  infarct myocardial area. AAR  area at risk; LAD  left anterior
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HIF-1 Reduces Myocardial Infarction December 6, 2005:2116–24igation in the peri-infarct and infarct regions (Fig. 3A). At
our weeks, HIF-1 was no longer detected in the region of
nfarction and was expressed at low levels in the peri-infarct
egion. In contrast, HIF-1() transgenic animals dis-
layed very high levels of HIF-1 protein in infarct and
eri-infarct areas immediately after coronary ligation, and
his pattern of expression persisted in hearts 4 weeks after
nfarction.
We confirmed that transgenic HIF-1 is expressed at
igh levels in cardiomyocytes of the infarcted heart (Fig.
B) by staining contiguous 5-m sections with antibodies
o HIF-1 and -MHC (data not shown). We then
valuated two genes whose sequences contain hypoxic re-
ponse elements and whose transcriptional activity is mod-
lated by HIF in other organ systems: VEGF and iNOS
14, 15). Although HIF-1() infarct animals manifest a
wo-fold increase in VEGF and iNOS protein in peri-
nfarct regions compared to noninfarcted septum, HIF-
() infarct animals showed a five-fold increase in VEGF
nd four-fold increase in iNOS expression in the peri-
nfarct region compared to nonischemic areas of the heart at
oth 24 h and 4 weeks after LAD ligation (Fig. 3).
ascular density measurement. To assess the angiogenic
ffect of constitutive HIF-1 expression 4 weeks after
oronary ligation, we measured vascular density in the
eri-infarct (border zone) region adjacent to the infarction,
ithin the infarction, and in the noninfarcted septal region
f the left ventricle (Fig. 4). We excised hearts and per-
ormed immunohistochemical staining with anti-CD31 an-
ibody to detect endothelial cells. Capillary density observed
n the peri-infarct area of the HIF-1() transgenic ani-
als (2,498  277/mm2) was significantly higher than that
f the HIF-1() group (1,015 320/mm2; p 0.01) and
he two sham-operated control groups (HIF-1() sham:
82  194/mm2; p  0.01; HIF-1() sham: 755 
igure 2. Northern blot analysis of transgenic and endogenous HIF-1 in
nfarct, peri-infarct, and remote left ventricular regions at 24 h and 4 weeks
fter LAD ligation and in sham-operated hearts.   HIF-1() hearts;
 HIF-1() hearts. Steady-state levels of transgenic HIF-1 mRNA
re not affected by hypoxic conditions, while steady-state levels of endog-
nous HIF-1 mRNA are increased in early infarct and peri-infarct
egions.72/mm2; p  0.01). We observed the increased capillary
4
sensity caused by transgenic HIF-1 also within the site of
nfarction. In the septal area that was remote from the
nfarct site, we observed no difference in vascularity between
roups. Angiogenesis in infarct/peri-infarct regions was
onfined to vessels measuring 200 m in diameter (Fig.
C).
ardiac performance 4 weeks after infarction in HIF-
() animals and controls. In the clinical setting, the
revention of progressive heart failure as a result of myo-
ardial infarction is of great importance. To this end, we
ssessed the cardiac function 4 weeks after myocardial
nfarction in HIF-1() and HIF-1() mice by echocar-
iography. The cardiac functional parameters evaluated by
chocardiography 4 weeks after LAD ligation are shown in
able 2. In the control group (HIF-1()/coronary liga-
igure 3. HIF-1() transgenic hearts show increased expression of
IF-1, VEGF, and iNOS in the peri-infarct region compared to control
IF-1() hearts. (A) Western blot analysis of HIF-1, VEGF, and
NOS in infarct, peri-infarct, and remote left ventricular regions at 24 h
nd 4 weeks after LAD ligation and in sham-operated hearts.  
IF-1() hearts;  HIF-1() hearts. (B) Immunohistochemical
ocalization of HIF-1, VEGF, and iNOS protein in peri-infarct areas at
weeks in HIF-1() and HIF-1 () hearts. Sections were counter-
tained with hematoxylin. Scale bar  80 m.
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December 6, 2005:2116–24 HIF-1 Reduces Myocardial Infarctionion), markedly decreased fractional shortening (FS) and
jection fraction (EF) with dilated left ventricular cavity area
t diastole (LVAD) and at systole (LVAS) were seen,
orresponding to postinfarction myocardial failure. In the
IF-1()/coronary ligation animals, significantly lower
VESD and LVEDD and greater FS and EF were ob-
erved compared with the control group (all p  0.05).
ham-operated animals had no evidence of myocardial
ysfunction as assessed by echocardiography.
yocardial pathology 4 weeks after infarction in HIF-
() animals and controls. Microscopic views of
richrome-stained hearts are shown in Figure 5. In HIF-
() and HIF-1() mice that underwent coronary
igation, positively stained fibrous infarcts were found in
he heart 4 weeks after myocardial infarction. Thin scars in
igure 4. Capillary densities at different locations in the infarcted heart. C
eri-infarct border zone, and (C) interventricular septum and similar anatom
ounted in a blinded fashion and expressed as the number/mm2. HIF-1
 10 animals, HIF-1()/sham n  10 animals.he area of infarction and dilated left ventricular cavities nere observed in the HIF-1() mice. In contrast, hearts in
he HIF-1() group had thicker infarcts with partial
reservation of cellularity within scar tissue. We measured
he infarct size and other parameters in the left ventricles at
he section located at the midpoint between ligation and
pex (16). Planar morphometric analysis of serial cross-
ections showed that despite comparable areas at risk
AARs), the infarct sizes were significantly smaller for the
IF-1() hearts than for the HIF-1() hearts 4 weeks
fter infarction, and both the percentage of infarct length
nd that of viable left ventricular area were significantly
igher in the HIF-1() group than in the HIF-1()
earts (Table 1, Figs. 5A and 5B). We also tested the effects
f constitutive HIF-1 in sham-operated animals to rule
ut the possibility of a hypertrophic action of HIF-1 under
positive capillary density was measured at three areas: (A) infarction, (B)
eas in sham-operated hearts. The number of CD31-stained capillaries was
I n  10 animals, HIF-1()/MI n  10 animals, HIF-1()/shamD31-
ic ar
()/Mormoxic conditions. No hypertrophy of cardiac muscles
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HIF-1() and HIF-1() hearts (n  10 for each group) 4 weeks after
coronary ligation in the peri-infarct region (C, scale bar  45 m).
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p
EF  ejection fraction; FS  fractional shortening; LV  left ventricle; LVAD  left
ventricular end-diastolic diameter; LVESD  left ventricular end-systolic diameter.
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data not shown).
ONCLUSIONS
critical component of myocardial ischemia is hypoxia,
hich triggers a wide range of cellular responses, including
egulation of gene expression and post-translational modi-
cations of proteins. The pathway for gene regulation in
esponse to hypoxia involves oxygen sensing followed by a
eries of signal transduction mechanisms that lead to induc-
ion or repression of transcription and changes in mRNA
tability or the rate of translation or degradation of protein
roduct. In multiple cell culture and animal models, it has
een demonstrated that the transcriptional activity, DNA
inding capability, and stability of the HIF-1 subunit are
irectly controlled by intracellular oxygen concentration.
As the rheostat for oxygen sensing in the cell, HIF-1
ontrols several pathways critical for cellular response to
ypoxia. These include: 1) the transcriptional activation of
ngiogenesis genes such as VEGF, angiopoietin-1 (Ang-1),
ngiopoietin-2 (Ang-2), placental growth factor, and
latelet-derived growth factor beta (17); 2) the recruitment
f endothelial progenitor cells to areas of tissue ischemia
hrough an SDF-1-CXCR4 pathway (18); 3) the precon-
itioning of tissue to tolerate ischemic insult (19,20); 4) the
timulation of solid organ tumor growth (21); and 5) the
ctivation of proinflammatory chemokine production by
ndothelium through transcriptional modulation of heme
xygenase 1 (22). Indeed, the Semenza group (23) has
eported that more than 2% of all human genes are
egulated by HIF-1 in human pulmonary artery endothelial
ells, confirming the broad range of effects this transcrip-
ional activator has on diverse classes of genes.
The focus of our research is to understand the role of
IF-1 in ischemia and infarction and to characterize the
HIF-1() (n  20)
p Value*24 h 4 weeks
4.40  0.13 5.41  0.11 0.05
3.88  0.13 4.75  0.12 0.01
11.9  1.20 12.3  0.92 0.05
71.5  4.38 68.2  3.91 0.05
59.4  4.28 44.0  4.42 0.01
34.1  5.34 48.2  4.40 0.01
35.1  5.31 27.5  5.72 0.01
3.49  0.08 3.50  0.09 0.43
2.03  0.09 2.07  0.08 0.83
42.1  1.02 42.8  1.31 0.64
56.8  6.97 57.1  7.21 0.72
25.8  5.18 25.9  5.37 0.79
71.2  5.05 71.4  5.77 0.45
to 4 weeks between HIF-1 () and HIF-1 () groups for each echocardiographicigure 5. Histology of infarcted hearts. Four weeks after infarction, hearts
ere excised, sectioned at the level of the papillary muscles, and stained
ith Masson’s trichrome (A, scale bar  1 mm, B, scale bar  200 m).
ore preservation of muscular architecture and greater number of peri-
nfarct vessels seen in HIF-1() hearts compared to HIF-1() controls.
mmunohistochemical staining with anti-CD31 monoclonal antibody inable 2. ECHO Parameters of LV Function
Time After
Coronary Ligation
HIF-1() (n  20)
24 h 4 weeks
AD ligation
LVEDD (mm) 4.39  0.28 5.99  0.22
LVESD (mm) 3.90  0.29 5.48  0.21
FS (%) 11.6  1.37 8.48  0.61
LVAD (mm2) 71.4  3.49 73.2  4.45
LVAS (mm2) 58.2  5.10 55.3  4.36
EF (%) 36.8  6.23 39.3  6.80
Akinetic area (mm2) 34.2  4.21 41.7  5.81
ham
LVEDD (mm) 3.54  0.69 3.52  0.07
LVESD (mm) 2.08  0.07 2.11  0.05
FS (%) 41.5  1.33 40.1  1.45
LVAD (mm2) 56.4  5.73 57.9  5.36
LVAS (mm2) 25.7  4.70 25.2  5.73
EF (%) 71.8  5.28 70.2  4.96
alues indicate mean SEM. *p Value compares mean magnitude of change from 24 hours
arameter.ventricular area at diastole; LVAS  left ventricular area at systole; LVEDD  left
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December 6, 2005:2116–24 HIF-1 Reduces Myocardial Infarctionffect of this gene product on myocardial angiogenesis in
ormoxic and hypoxic conditions. Our results demonstrate
hat modulation of the gene target HIF-1 in the heart
romoted angiogenesis, led to attenuation of infarct size,
nd improved cardiac performance after MI in the mouse.
e show that overexpression of HIF-1 in our transgenic
odel allows for supranormal levels of this protein in
ypoxic (infarct/peri-infarct) myocardium. This is presum-
bly due to the fact that levels of transgenic HIF-1 protein,
tabilized under hypoxic conditions, exceed the known
egradation pathway for this protein. Normally, HIF-1 is
egulated at the level of protein stability, with a short
alf-life and rapid ubiquitination in normoxic conditions
nd a much longer half-life and reduced ubiquitination in
ypoxic conditions (24). Hypoxia is also known to trigger
ranscriptional activation of the endogenous HIF-1 gene
ithin several organs, including human myocardium (2).
Two competing processes modulate the amount of HIF-1
rotein in the ischemic heart: production and degradation.
e found that under normoxic conditions, transgenic
IF-1 was constitutively expressed at the level of mRNA
promoter expresses transgene regardless of cellular oxygen
ension) and endogenous HIF-1 was not expressed. Nor-
al partial pressures of cellular oxygen have been shown to
timulate rapid degradation of the HIF-1 protein. Thus,
nder normoxic conditions, although HIF-1 was consti-
utively expressed at the mRNA level in transgenic animals,
e found it was barely detectable at the protein level.
In contrast, we found that under hypoxic conditions,
ransgenic HIF-1 was constitutively expressed at the level
f mRNA (promoter expresses transgene regardless of
ellular oxygen tension), and endogenous HIF-1 was also
xpressed. The transcription of the endogenous HIF-1
ene is exquisitely sensitive to the onset of cellular hypoxic
onditions, making it one of the earliest effectors of the
esponse to ischemia. Hypoxia led to the stabilization of
IF-1 protein (both transgenic and endogenous) in areas
f ischemia, allowing us to measure high levels of HIF-1
rotein in infarct and peri-infarct tissue at 24 h after
oronary ligation.
In the myocardium of HIF-1() mice, a marked
ncrease in blood vessels in the peri-infarct and infarct
egions was observed. Sufficient blood flow as a result of this
ncreased blood vessel formation might be instrumental to
revention of the loss of cardiomyocytes in these zones over
ime, preservation of contractility in the border zone adja-
ent to the infarct, and suppression of postinfarction cardiac
ailure during left ventricular remodeling. Myocardial dete-
ioration after infarction in HIF-1() animals may be
imited, not only as a result of stimulation of angiogenesis
hrough a VEGF-related pathway, but also through addi-
ional HIF-1–mediated local adaptations to low oxygen
ension, such as recruitment of scaffolding progenitor cells,
asodilatation through an iNOS-related pathway, protec-
ion from oxidant stress, and a transition to anaerobic
etabolism.
1So far, efforts to stimulate angiogenic response in the
eart have been limited to the introduction of exogenous
rowth factors such as fibroblast growth factors (FGFs) or
EGFs (25,26) and stabilizing proteins such as VP-16 and
R39 (27,28) by means of gene or protein delivery. Our
eport suggests the possibility of using the -subunit of the
ranscriptional enhancer HIF-1 alone to stimulate angio-
enic response to hypoxia, without the known reported side
ffects of excessive unregulated myocardial VEGF, such as
ragile and immature vessels, angioma formation, and elic-
tation of systemic hypotension (29,30).
In summary, although multiple genes undoubtedly con-
ribute to remodeling of the left ventricle after infarction, we
how that a single gene, HIF-1, induces therapeutic
ngiogenesis, limits infarct size, and improves myocardial
unction after acute coronary occlusion. Our results may
ave important practical implications for the treatment of
atients with severe myocardial ischemia.
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